These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 11806630)

  • 1. In vitro effects of ampicillin, ciprofloxacin and ofloxacin on Salmonella typhi within human monocyte-derived macrophages.
    Ekinci B; Coban AY; Durupinar B
    J Chemother; 2001 Dec; 13(6):661-3. PubMed ID: 11806630
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
    Threlfall EJ; Ward LR
    Emerg Infect Dis; 2001; 7(3):448-50. PubMed ID: 11384525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin-resistant Salmonella typhi.
    Baliga S; Shenoy S; Vidyalaxmi ; Pereira P
    Natl Med J India; 1999; 12(3):138. PubMed ID: 10492594
    [No Abstract]   [Full Text] [Related]  

  • 4. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
    Ciraj AM; Seema DS; Bhat GK; Shivananda PG
    Indian J Pathol Microbiol; 2001 Oct; 44(4):407-8. PubMed ID: 12035350
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergism of ciprofloxacin and trimethoprim against Salmonella enterica serovar typhi isolates showing reduced susceptibility to ciprofloxacin.
    Mandal S; Mandal MD; Pal NK
    Chemotherapy; 2004 Jun; 50(3):152-4. PubMed ID: 15272228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin-resistant Salmonella typhi.
    Bhat KG; Suresh K
    Natl Med J India; 1999; 12(2):88. PubMed ID: 10416331
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug resistance in Salmonella typhi in north India with special reference to ciprofloxacin.
    Nath G; Tikoo A; Manocha H; Tripathi AK; Gulati AK
    J Antimicrob Chemother; 2000 Jul; 46(1):149-50. PubMed ID: 10882709
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of the level of ampicillin resistance and the inoculum size on the in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium.
    Tripodi MF; Rambaldi A; Sarnataro G; Ragone E; Utili R
    J Antimicrob Chemother; 1999 Nov; 44(5):719-20. PubMed ID: 10552994
    [No Abstract]   [Full Text] [Related]  

  • 9. Revised ciprofloxacin breakpoints for Salmonella Typhi: its implications in India.
    Balaji V; Sharma A; Ranjan P; Kapil A
    Indian J Med Microbiol; 2014; 32(2):161-3. PubMed ID: 24713903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.
    Madhulika U; Harish BN; Parija SC
    Indian J Med Res; 2004 Aug; 120(2):111-4. PubMed ID: 15347861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.
    Joshi S; Amarnath SK
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):308-10. PubMed ID: 16950486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The susceptibility of Salmonella sp. to various antibiotics].
    Willke A; Altay G; Erdem B
    Mikrobiyol Bul; 1988 Jan; 22(1):17-24. PubMed ID: 3273593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical resistance to ciprofloxacin in Salmonella typhi.
    Rodrigues C; Mehta A; Andrews R; Joshi VR
    J Assoc Physicians India; 1998 Mar; 46(3):323-4. PubMed ID: 11273362
    [No Abstract]   [Full Text] [Related]  

  • 14. Ofloxacin minimum inhibitory concentration versus disk diffusion zone diameter for Salmonella enterica serovar Typhi isolates: problems in the detection of ofloxacin resistance.
    Mandal S; Mandal MD; Pal NK
    Jpn J Infect Dis; 2003; 56(5-6):210-2. PubMed ID: 14695432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin reduces the antimicrobial activity of ciprofloxacin against Salmonella typhimurium and Salmonella typhi.
    Marathe SA; Kumar R; Ajitkumar P; Nagaraja V; Chakravortty D
    J Antimicrob Chemother; 2013 Jan; 68(1):139-52. PubMed ID: 23070736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of standard proportion dilution test and Etest for Mycobacterium tuberculosis sensitivity to ofloxacin and ciprofloxacin].
    Cavuşoğlu C; Ciçek-Saydam C; Burhanoğlu D; Ozkalay N; Ozkaya D; Ozçam H; Bilgiç A
    Mikrobiyol Bul; 2002 Jan; 36(1):118-23. PubMed ID: 12476777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India.
    Dutta S; Sur D; Manna B; Sen B; Bhattacharya M; Bhattacharya SK; Wain J; Nair S; Clemens JD; Ochiai RL
    Int J Antimicrob Agents; 2008 Apr; 31(4):387-9. PubMed ID: 18280709
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
    Kim DM; Neupane GP; Jang SJ; Kim SH; Lee BK
    Int J Antimicrob Agents; 2010 Aug; 36(2):155-8. PubMed ID: 20478696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella typhi.
    Kapil A; Renuka ; Das B
    Indian J Med Res; 2002 Feb; 115():49-54. PubMed ID: 12138664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance among Streptococcus pneumoniae isolated at a university hospital in eastern Tennessee.
    Baddour LM; Smith EA
    Clin Infect Dis; 1999 Jul; 29(1):224-5. PubMed ID: 10433604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.